Imidazolate‐Stabilized Cu(III): Dioxygen to Oxides at Type 3 Copper Sites
Angewandte Chemie International Edition · 27.01.2025 · 64 (5)
DOI: 10.1002/anie.202416967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 27.11.2024. Verfasst von Tao A G Large und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Stanford University Stanford, California, 94305, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Imidazole ligation of metals through histidine is extensive among metalloproteins, yet the role of the imidazol ate conjugate base is often neglected, despite its potential accessibility when bonded to an oxidized metal center. Using synthetic models of oxygenated tyrosinase enzymes ligated exclusively by monodentate imidazoles, we find that deprotonation of the μ 2 ‐η 2 :η 2 ‐peroxidodicopper(II) species triggers redox isomerization to an imidazol ate ‐ligated bis(μ 2 ‐oxido)dicopper(III) species. Formal two‐electron oxidation to Cu(III) remains biologically unprecedented, yet is effected readily by addition of base. Spectrophotometric titrations by UV/Visible/near‐IR and copper K‐edge X‐ray absorption spectroscopies are interpreted most simply as two cooperative, 2H + transformations in which the peroxide O−O is cleaved in the first step. Elaboration from simple imidazoles to a protected histidine extends this isomerization into an amino acid environment. The role of phenolate as a base suggests this four‐electron reduction of O 2 is energetically viable in a biological context and requires only two copper centers, which act as two‐electron shuttles when imidazole deprotonation assists. This existential precedent of viable imidazol ate intermediates invites speculation into an alternative mechanism for phenol hydroxylation not previously considered at Type 3 copper sites such as tyrosinases. Structural biological evidence suggests imidazolate ligation of copper may be more widespread than generally understood.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Stanford University Stanford, California, 94305, USA.
- Department of Chemistry & Biochemistry, Stephen F. Austin State University Nacogdoches, TX, 75962, USA.
- Department of Chemistry, University of the Fraser Valley Abbotsford, BC, Canada.
ORCID-Profile: Tao A G Large, William Keown, J Brannon Gary, Linus Chiang, T Daniel P Stack
Förderung
- NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Large, T. A. G., Keown, W., Gary, J. B., Chiang, L., & Stack, T. D. P. (2025). Imidazolate‐Stabilized Cu(III): Dioxygen to Oxides at Type 3 Copper Sites. Angewandte Chemie International Edition, 64(5). https://doi.org/10.1002/anie.202416967
Vancouver
Large TAG, Keown W, Gary JB, Chiang L, Stack TDP. Imidazolate‐Stabilized Cu(III): Dioxygen to Oxides at Type 3 Copper Sites. Angewandte Chemie International Edition. 2025;64(5). doi:10.1002/anie.202416967
BibTeX
@article{Large2025,
author = {Large, Tao A G and Keown, William and Gary, J Brannon and Chiang, Linus and Stack, T Daniel P},
title = {Imidazolate‐Stabilized Cu(III): Dioxygen to Oxides at Type 3 Copper Sites},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {5},
doi = {10.1002/anie.202416967}
}
EUVIMED